Psoriasis affects approximately 125 million people worldwide, representing 2-3% of the global population, and significantly impacts quality of life through chronic inflammation and associated comorbidities. This complex autoimmune condition requires specialized dermatologic expertise and advanced treatment approaches to achieve optimal disease control and prevent long-term complications.
Dr. Zitelli brings unique clinical research experience from her work with Dr. John Koo, world-renowned psoriasis authority, at the UCSF San Francisco Psoriasis Treatment Center, providing Cincinnati patients with cutting-edge psoriasis management and personalized biologic therapy protocols.
Not only provides excellent care but truly cares.
Identifying Psoriasis Subtypes and Disease Patterns
Psoriasis manifests in multiple forms requiring individualized assessment and targeted treatment approaches based on disease severity, location, and response patterns.
Chronic Plaque Psoriasis
Most common presentation with well-demarcated silvery-scaled plaques requiring sustained treatment protocols and careful monitoring
Guttate Psoriasis
Small, teardrop-shaped lesions often triggered by streptococcal infections requiring prompt intervention and infection management
Inverse Psoriasis
Smooth, red patches in skin folds presenting unique treatment challenges due to location sensitivity and occlusion factors
Pustular and Erythrodermic Variants
Severe forms requiring immediate medical attention, hospitalization considerations, and aggressive systemic therapy protocols
Revolutionary Biologic Treatment Approaches
Modern psoriasis management leverages advanced biologic therapies targeting specific inflammatory pathways with unprecedented efficacy and improved safety profiles.
TNF-Alpha Inhibitor Protocols
Established biologic therapies including adalimumab, etanercept, and infliximab with proven track records for moderate-to-severe disease control
Interleukin-17 Pathway Targeting
Next-generation biologics including secukinumab and ixekizumab offering rapid clearance and sustained remission for qualifying patients
IL-23 Inhibitor Innovations
Newest biologic class including guselkumab and risankizumab providing exceptional long-term outcomes with extended dosing intervals
Personalized Biologic Selection
Research-driven approach utilizing patient-specific factors, comorbidity profiles, and response predictors for optimal medication matching
Clinical Research-Informed Treatment Strategies for Psoriasis
Dr. Zitelli’s experience at the UCSF San Francisco Psoriasis Treatment Center with Dr. John Koo provides access to cutting-edge treatment protocols and research-based approaches.
This specialized background enables implementation of the latest evidence-based therapies, participation in clinical trials when appropriate, and application of advanced treatment algorithms developed through academic collaboration. Patients benefit from treatment approaches informed by the most current psoriasis research and international treatment guidelines.
Comprehensive Comorbidity Management and Monitoring
Successful psoriasis care requires ongoing assessment for associated conditions including cardiovascular disease, metabolic syndrome, and psychological comorbidities.
Regular monitoring protocols include cardiovascular risk assessment, metabolic screening, and mental health evaluation. Collaborative care with specialists ensures comprehensive management of psoriasis-associated conditions while optimizing treatment outcomes and preventing complications.
Frequently Asked Questions About Psoriasis Treatment
Modern biologics can achieve 75-90% skin clearance in many patients, with some achieving complete clearance and sustained remission with appropriate treatment selection.
Current evidence supports long-term biologic safety with appropriate monitoring, though individual risk assessment and regular follow-up remain essential for optimal outcomes.
Treatment selection considers disease severity, previous treatment responses, comorbidity profile, lifestyle factors, and patient preferences in a personalized approach.
While psoriasis cannot be permanently cured, modern treatments can achieve long-term remission and excellent disease control for most patients.
Monitoring frequency varies by medication but typically includes baseline testing and periodic blood work every 3-6 months to ensure safety and effectiveness.
Board-Certified Dermatologist Serving Cincinnati, Ohio
Dr. Kristine Zitelli is a board-certified dermatologist serving the Cincinnati area, known for her expertise in treating a wide range of skin conditions. She completed her medical degree at Wright State University and dermatology residency at the University of Cincinnati, with additional advanced training at the UCSF Psoriasis and Skin Treatment Center. Her clinical focus includes thorough skin examinations, psoriasis, eczema, complex medical dermatology, surgical dermatology and cosmetic treatments using the latest technologies.
Dr. Zitelli has been named a “Top Doctor” in Cincinnati every year since 2016 as well as Cincinnati’s Top Dermatologist in 2020. She remains dedicated to educating the community about skin health and sun safety. Combining academic excellence, clinical research, and a compassionate approach, Dr. Zitelli delivers personalized, evidence-based care to every patient.
Advanced Psoriasis Care in Cincinnati
Transform your psoriasis management with research-informed treatment approaches and cutting-edge biologic therapies. Dr. Zitelli’s specialized training with world-renowned psoriasis authorities provides Cincinnati patients with access to the most advanced treatment protocols and personalized care strategies.
Schedule your comprehensive psoriasis evaluation today to experience the difference that clinical research expertise makes in achieving optimal disease control and improved quality of life.
